Study design
This was a retrospective, multi-surgeon, case-matched cohort study from a single academic tertiary referral unit between January 2016 and December 2022. The study was approved by the institutional review board.
An a priori sample size calculation was performed. Based on a difference in complication rate of 4% between hybrid and uncemented THAs (18) and an enrollment ratio 1:2, a minimum of 121 cases in the cemented AA-THA group and 242 cases in the uncemented AA-THA group was needed to achieve sufficient power (1-b= 0.80, α = 0.05).
Study Population
In 2018, hybrid AA-THA using a cemented femoral component was introduced in our unit’s elective arthroplasty practice (15). This was aimed to reduce our institutional PFF rate with the AA-THA which was previously reported to be between 3.4 – 4.35% (19,20). For this study, the first 122 hybrid AA-THAs with a cemented PTS femoral stem with a minimum of 12-month follow-up were included for review. These cases were performed by one of three fellowship-trained arthroplasty surgeons (PEB, SG, GG) well experienced with AA-THA. All cases were obtained from a prospectively maintained arthroplasty database at our institution. Inclusion criteria included consecutive adult patients (≥18 years) who underwent primary, elective, AA-THA with a cemented stem for an indication of osteoarthritis (OA). We excluded all patients with a diagnosis other than OA, and those who received a hip hemiarthroplasty, hip resurfacing arthroplasty, or revision THA performed through an anterior approach. Our initial institutional experience of the first 58 cemented femoral components, regardless of arthroplasty-type, has been previously described (15).
To compare outcomes between hybrid AA-THAs and AA-THA performed with an uncemented stem, we retrospectively retrieved prospectively collected data from our institutional arthroplasty database of patients who underwent elective, primary, AA-THA with a short cementless, titanium, flat, tapered stem (Taperloc Microplasty Complete Hip System, Zimmer-Biomet, Warsaw, Indiana, USA), between January 1, 2016 and October 31, 2018. Only cases for an indication of OA and performed by the same surgeons were included (n = 901). To minimize variability and balance cohorts with respect to baseline characteristics, patients who underwent AA-THA with a cemented stem were matched for patient factors known to influence PPF risk (age, sex, body mass index (BMI), Dorr classification and femoral and pelvic morphological characteristics) in a 1:2 fashion with 244 uncemented AA-THAs (Table 1).
Surgical Procedure
All patients received preoperative antibiotics and 1 gram of intravenous tranexamic acid (TXA) prior to skin incision. Decision to use a general or spinal anesthetic reflected the anesthesiologist’s and patient’s decision.
All surgeries were performed either using a standard operating table or an orthopaedic positioning table (Hana Orthopedic Surgery Table, Mizuho OSI, Union City, CA or RotexTable, Condor, MedTec). A cementless acetabular cup was used in all patients (G7 Acetabular Shell; Zimmer Biomet, Warsaw, IN) with a highly cross-linked polyethylene liner. Three different PTS femoral stems were used: Exeter Femoral Hip Stem (Stryker) n=64 (53%); Sirius Cemented Femoral Hip Stem (Zimmer Biomet) n= 40 (33%); C-Stem AMT (Depuy Synthes) n=18 (14%) - all collarless highly polished double-taper design. The choice of femoral stem depended on inventory of femoral stem at the site where surgery took place. The Sirius stem stopped being available in North America in 2020. All stems were cemented in standard fashion using 3rd generation cementing technique. Antibiotic cement was used in all cases (Palacos+G, Heraeus Medical, Germany). The short Exeter stem (125mm in length 37.5 and 44mm offset stems) were used in 33 cases.
A standardized postoperative protocol was followed in all patients, allowing immediate full weight bearing. All patients were assessed by physiotherapy before hospital discharge. Routine, 30-day deep venous thrombosis (DVT) prophylaxis was used in all cases. Patients were reviewed clinically at 2 weeks, 6 weeks, 6 months, 12 months, and annually thereafter.
Outcome Measurements
Outcome measures included PPF rate, revision arthroplasty rate, and intraoperative and postoperative complications. The Dindo-Clavien classification system was used to grade complications (21). Grade 1 complications needed no treatment. Grade 2 complications required pharmacologic treatment, including superficial wound infections treated with antibiotics. Grade 3 complications resulted in reoperation, including PPF, periprosthetic joint infection (PJI), subsidence, instability, and aseptic joint loosening. Grade 4 complications were potentially life-threatening complications, and grade 5 complications resulted in death.
Radiographic assessments were performed on antero-posterior (AP) pelvic radiographs. Post-operative radiographs at 6 weeks served to evaluate cementation quality using the Barrack and Harris grading system (22) and stem coronal alignment (neutral: varus/valgus 0±3º; varus 3-5º; varus >5º) (Figure 1). Similarly, stem subsidence assessment was done based on radiographs obtained at the 1-year follow-up, or last available radiograph in patients who fractured earlier. Injury radiographs of all patients with a PFF were retrieved and reviewed by a fellowship-trained arthroplasty surgeon (JBM). Fractures were categorized using the Vancouver classification system (23). In addition, radiographic measurements of proximal femur and pelvic morphological parameters were performed using pre-operative supine radiographs (20). All radiographs included a 25 mm marker to avoid magnification error. Analysis was performed by 2 fellowship-trained arthroplasty surgeons (JBM and GG) with previously described excellent intra- and inter-observer coefficients (0.720-0.990 and 0.751-0.970, respectively) (20) using the criteria defined by Landis and Koch (24). Proximal femoral geometry was measured using canal-flare index (CFI) (25), canal-calcar ratio (CCR) (26), canal-bone ratio (CBR) (27), and the morphological cortical index (MCI) (28). Pelvic parameters measured include the ilium-ischial ratio (IIR) (29) and the distance from the anterior superior iliac spine to the tip of the greater trochanter (ASIS-GT). These measurements can be calculated on the pelvic AP radiograph (Figure 2).
Data Analyses
Descriptive statistics are presented as means and standard deviations. Categorical variables are presented as absolute numbers and percentages. Non-parametric tests were used for data analysis. The Mann Whitney U test was used to compare continuous data between groups. Cross-tabulated data was compared using the chi-squared test, or Fisher’s Exact test where any expected cell count was <5, and odds ratios (with 95% confidence intervals (CI)) were calculated. Correlations were tested using Spearman’s rho. Factors that were independent predictors of fracture were determined using univariate and multivariate analysis. Variables that were correlated with one another were removed from the multivariate analysis. All statistical analysis was performed using SPSS Statistical Software (version 27.0, SPSS Inc., Armonk, New York). Statistical significance was set at p<0.05.